Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 16 2025
0mins
Should l Buy TMDE?
Source: Benzinga
Incyte Corporation's Stock Surge: Incyte shares rose 9.6% to $74.25 in pre-market trading following a collaboration announcement with QIAGEN to develop companion diagnostics for mutant CALR-expressing Myeloproliferative Neoplasms.
Pre-Market Trading Highlights: Several stocks experienced significant movements, including TMD Energy Limited (+203%), Regencell Bioscience Holdings (+169.6%), and Sarepta Therapeutics (-31.4%) after halting shipments and trials due to safety concerns.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TMDE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TMDE
About TMDE
TMD Energy Limited is a holding company. The Company provides marine fuel bunkering services in the supply and marketing of marine gas oil and marine fuel oil, which include high sulfur fuel oil, low sulfur fuel oil and very low sulfur fuel oil, to ships and vessels at sea. It is also involved in the provision of ship management services for in-house and external vessels, as well as vessel chartering services. It operates over 15 well-maintained bunkering vessels and operates in 19 ports in Malaysia, including Lumut Port, Penang Port, Malacca Port, and others. Its range of bunkering services caters to various types of seafaring vessels, including container vessels, oil tankers, cruise ships, and accommodation work barges such as floating production storage and offloading units and floating storage and offloading units, supply and support vessels such as platform supply vessels and research vessels. Its offshore structures include semi-submersible rigs, jackup rigs and drillships.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Acquisition Agreement: Lisata Therapeutics Inc has agreed to be taken private by Kuva Labs, offering shareholders $5.00 per share along with a $1.00 contingent value right per share, indicating recognition of the company's future potential.
- Significant Stock Surge: Following the acquisition announcement, Lisata Therapeutics' shares rose 20.3% in pre-market trading to $5.03, reflecting positive market reaction and increased investor confidence in the deal.
- Impact of Privatization: The acquisition will result in Lisata Therapeutics delisting from public markets, potentially providing the company with greater flexibility to focus on long-term strategic goals while mitigating the impact of market volatility on its operations.
- Market Dynamics Shift: The announcement of this deal has sparked interest in other related stocks, demonstrating investor enthusiasm for M&A activity in the biotech sector, which may influence future investment decisions and market trends.
See More
- Stock Surge: TMD Energy Ltd. (AMEX:TMDE) shares rose 16.09% to $3.52 in premarket trading on Friday, following a massive 37.56% gain on Thursday, indicating strong market response and investor confidence in the company's growth prospects.
- Year-to-Date Performance: Year-to-date, TMDE's stock has surged 606.98%, reflecting robust performance in the marine fuel supply market, particularly against the backdrop of rising global oil prices, which further strengthens its market position.
- Oil Price Surge Context: The escalation of the Middle East conflict has driven WTI crude oil futures above $84 per barrel on Friday, on track for the largest weekly gain since 2022, directly impacting TMD Energy's business outlook, especially with shipping nearly halted through the Strait of Hormuz.
- Technical Analysis Signals: Despite a 16.25% decline over the past year, current technical indicators suggest a turnaround, with the stock trading significantly above key moving averages—199.3% above the 20-day SMA, 301.6% above the 50-day SMA, 338.9% above the 100-day SMA, and 285.9% above the 200-day SMA—indicating optimistic market sentiment regarding its future performance.
See More
- Significant Sales Growth: Smith & Wesson reported third-quarter sales of $135.71 million, reflecting a 17.1% year-over-year increase, surpassing the market expectation of $125.59 million, indicating strong growth momentum in a competitive market.
- Improved Profitability: The company posted earnings per share of $0.08, exceeding the consensus estimate of $0.05, showcasing enhanced cost control and operational efficiency, which boosts investor confidence in future profitability.
- Stock Price Surge: Following the earnings report, Smith & Wesson's shares jumped 10.8% in pre-market trading to $13.06, indicating a positive market reaction to its performance, potentially attracting more investor interest.
- Enhanced Market Outlook: The better-than-expected results may improve market optimism regarding the company's future performance, further driving stock price increases and strengthening its competitive position in the industry.
See More
- Dow Jones Performance: The Dow Jones index gained over 100 points on Wednesday, rising 0.25% to close at 48,622.74, indicating positive market sentiment and increased investor confidence.
- NASDAQ and S&P 500 Rise: The NASDAQ climbed 0.69% to 22,672.12, while the S&P 500 rose 0.37% to 6,841.53, reflecting strong performances in the technology and consumer sectors.
- Abercrombie & Fitch Earnings: The company reported Q4 earnings of $3.68 per share, beating analyst expectations of $3.57, yet its stock fell around 5%, indicating market concerns about future performance.
- Private Sector Job Data: U.S. private businesses added 63,000 jobs in February, significantly exceeding market estimates of 50,000, suggesting a robust economic recovery that could positively impact the stock market.
See More
- Stock Surge: Delixy Holdings' shares surged 158.03% in after-hours trading to $2.12, reflecting investor expectations of future supply tightness, despite a 17.47% intraday drop earlier in the day.
- Strait of Hormuz Situation: The stock's movement follows U.S.-Israeli strikes against Iran, prompting Tehran to consider closing the Strait of Hormuz, a crucial global oil transport route, which heightens market concerns over oil supply.
- Market Performance Analysis: With a market capitalization of $13.65 million, Delixy Holdings has seen its stock price fall 83.4% over the past year, currently trading near its 52-week low of $0.61, indicating a long-term consolidation trend but a short-term rebound potential.
- Technical Indicators: The Relative Strength Index (RSI) for DLXY stands at 43.25, suggesting potential for a short-term rebound, and combined with market data, investors appear optimistic about its future performance.
See More
- Stock Volatility: Trio Petroleum Corp. (NYSE:TPET) shares fell 8.83% to $1.03 in after-hours trading on Monday, despite a massive 169.05% intraday gain, reflecting market concerns over Middle East oil supply disruptions.
- Geopolitical Impact: The stock's volatility is closely tied to U.S.-Israeli strikes on Iran and Tehran's closure of the Strait of Hormuz, a critical route for global crude oil, highlighting the geopolitical risks affecting the energy sector.
- Market Sentiment: The company holds a majority stake in 9,300 acres at California's South Salinas project, and its stock has dropped 18.12% over the past 12 months, indicating challenges for its long-term outlook, with the current price at about 39.9% of its 52-week low.
- Trading Metrics: Trio Petroleum has a market capitalization of $13.9 million and a 52-week trading range of $0.36 to $2.29, with a Relative Strength Index (RSI) of 76.14, suggesting a negative price trend across all time frames.
See More








